98063905 - TDOI

Information

• Trademark
• 98063905

• Source

• Serial Number

  98063905

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  June 28, 2023
  a year ago

• Transaction Date

  February 16, 2024
  a year ago

• Status Date

  February 16, 2024
  a year ago

• Location Date

  February 16, 2024
  a year ago

• Status Code

  602

• Current Location

  TMEG LAW OFFICE 109 - EXAMINING ATTORNEY ASSIGNED

  Employee Name

  LOBO, DEBORAH E

• Attorney Docket Number

  221834-00051

  Attorney Name

  Melanie Howard

  Law Office Assigned Location Code

  L90

• Owners

  • Replimune Limited

Case File Statements

• GS0051: Pharmaceutical preparations; viruses; viruses for the treatment of disease; viruses for the treatment of cancer; viruses for inducing immune response; pharmaceuticals; pharmaceuticals for the treatment of cancer; pharmaceuticals for inducing immune response; vaccines; immunotherapy products; gene therapy products; Biological preparations in the nature of viruses for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; biological preparations in the nature of viruses for the treatment of cancer; biological preparations in the nature of viruses for inducing immune response; pharmaceuticals, namely, pharmaceutical preparations and pharmaceutical substances for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; pharmaceuticals, namely, anti-infectives for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; pharmaceuticals for the treatment of cancer; pharmaceutical preparations for inducing immune response; vaccines; immunotherapy products, namely, pharmaceutical products for the prevention and treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; gene therapy products, namely, therapeutics for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders
• GS0421: Pharmaceutical drug research and development services; research and development of vaccines and medicines; information, advisory and consultancy services relating to the aforesaid

Case File Event Statements

• 2/16/2024 - a year ago

  8 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Type: MAB2

• 2/16/2024 - a year ago

  7 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2

• 11/2/2023 - a year ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 11/2/2023 - a year ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 11/2/2023 - a year ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 10/24/2023 - a year ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 7/31/2023 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 7/1/2023 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP